血管閉鎖デバイス市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年10月

血管閉鎖デバイス市場:タイプ(パッシブアプロキシメーター、アクティブアプロキシメーター、外部止血装置)、アクセス(大腿骨、橈骨)、手順(インターベンショナル心臓病学、インターベンショナルラジオロジー/血管外科)- 2026年までの世界予測

Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) – Global Forecast to 2026

ページ数177
図表数182
種別英文調査報告書

目次 お問合せ

The global vascular closure devices market is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period. The growth in this market can be attributed to a large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries. Emerging markets providing growth opportunities for market players and growth in the number of hospitals & surgical centers are expected to offer strong growth opportunities for players in the market. In contrast, the need for highly skilled professionals, risks associated with vascular closure devices, and stringent regulatory framework may challenge market growth to a certain extent. The vascular closure devices market is segmented based on type, access, procedure, and region.

“Passive approximators segment is expected to dominate the market during the forecast period.”

Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.

“Radial access segment to dominate the market during the forecast period.”

Based on access, the vascular closure devices market is segmented into radial access and femoral access. The femoral access segment commanded the largest share of the vascular closure devices market. . The large share of this segment can be attributed to the advantages of femoral access, such as better patient comfort, cost-effectiveness, and reduced hospitalization time.

“Interventional cardiology segment to dominate the market during the forecast period.”

Based on procedure, the vascular closure devices market is segmented into interventional cardiology procedures and interventional radiology/vascular surgery. Interventional cardiology for the largest share of the vascular closure devices market. The large share is attributed to the diagnosis and treatment of numerous cardiovascular disorders due to advancements in angioplasty and cardiac stenting and the growing prevalence of cardiac disorders globally.

“North America will dominate the market during the forecast period.”

The global vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.

The primary interviews conducted for this report can be categorized as follows:

•By Company Type – Tier 1: 52%, Tier 2: 30% and Tier 3: 18%
•By Designation – C-level: 45%, D-level: 30%, and Others: 25%
•By Region – North America: 36%, Europe: 24%, Asia Pacific: 29%, and Rest of World: 11%

List of Companies Profiled in the Report
•Terumo Corporation (Japan)
•Abbott (US)
•Cardinal Health (US)
•Cardiva Medical, Inc. (US)
•Medtronic Plc (Ireland)
•Morris Innovative, Inc. (US)
•Teleflex Incorporated (US)
•Merit Medical Systems, Inc. (US)
•Vasorum Ltd. (Ireland)
•TZ Medical, Inc. (US)
•Vivasure Medical Ltd. (Ireland)
•Tricol Biomedical (US)
•Scion Biomedical (US)
•Advanced Vascular Dynamics (US)
•Marine Polymer Technologies, Inc. (US)
•Transluminal Technologies (US)
•Rex Medical (US)
•Meril Life Sciences Pvt. Ltd. (India)
•Medas USA (US)
•Vygon Company (France)

Research Coverage:
This report provides a detailed picture of the global vascular closure devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, access, procedure and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vascular closure devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on vascular closure devices offered by the top 20 players in the vascular closure devices market. The report analyses the vascular closure devices market by type, access, procedure and region.

•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various vascular closure devices across key geographic regions.

•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular closure devices market.

•Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the vascular closure devices market.


目次

1INTRODUCTION24
1.1OBJECTIVES OF THE STUDY24
1.2MARKET DEFINITION24
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY24
1.3MARKET SCOPE25
FIGURE 1VASCULAR CLOSURE DEVICES MARKET SEGMENTATION25
1.3.1YEARS CONSIDERED FOR THE STUDY25
1.4CURRENCY26
1.5STAKEHOLDERS26
1.6SUMMARY OF CHANGES26
2RESEARCH METHODOLOGY27
2.1RESEARCH DATA27
FIGURE 2RESEARCH DESIGN27
2.2SECONDARY DATA28
2.2.1SECONDARY SOURCES29
2.3PRIMARY DATA30
FIGURE 3PRIMARY SOURCES30
2.3.1KEY DATA FROM PRIMARY SOURCES31
2.3.2KEY INDUSTRY INSIGHTS32
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION33
2.4MARKET SIZE ESTIMATION33
FIGURE 5MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH34
2.4.1GROWTH FORECAST35
FIGURE 6CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS35
FIGURE 7TOP-DOWN APPROACH36
2.5MARKET BREAKDOWN AND DATA TRIANGULATION37
FIGURE 8DATA TRIANGULATION METHODOLOGY37
2.6MARKET SHARE ANALYSIS38
2.7ASSUMPTIONS FOR THE STUDY38
2.7.1COVID-19-SPECIFIC ASSUMPTIONS39
2.8LIMITATIONS39
2.9RISK ASSESSMENT40
2.10COVID-19 ECONOMIC ASSESSMENT40
2.11ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO41
FIGURE 9CRITERIA IMPACTING THE GLOBAL ECONOMY41
FIGURE 10RECOVERY SCENARIO OF THE GLOBAL ECONOMY42
3EXECUTIVE SUMMARY43
FIGURE 11VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)43
FIGURE 12VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021 VS. 2026 (USD MILLION)44
FIGURE 13VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION)44
FIGURE 14VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021 VS. 2026 (USD MILLION)45
4PREMIUM INSIGHTS46
4.1VASCULAR CLOSURE DEVICES MARKET OVERVIEW46
FIGURE 15LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH46
4.2VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021–2026)47
FIGURE 16PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD47
4.3NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET,
BY TYPE AND COUNTRY (2020)48
FIGURE 17THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 202048
4.4VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES49
FIGURE 18US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD49
5MARKET OVERVIEW50
5.1INTRODUCTION50
FIGURE 19VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES50
5.2MARKET DYNAMICS51
5.2.1DRIVERS51
5.2.1.1Growing approvals of vascular closure devices51
TABLE 1APPROVALS OF VASCULAR CLOSURE DEVICES51
5.2.1.2High prevalence of cardiovascular diseases51
5.2.1.3Increasing prevalence of obesity52
5.2.1.4Increasing focus of market players on large-bore vascular closure devices52
5.2.1.5Growing geriatric population52
5.2.1.6Favorable reimbursement scenario for interventional radiology procedures53
TABLE 2REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US53
5.2.1.7Rising focus on effective blood loss management in patients during surgeries54
5.2.1.8Increasing investments, funds, and grants for research on vascular devices54

5.2.2RESTRAINTS54
5.2.2.1Increasing preference for interventional procedures using radial artery access54
5.2.2.2High cost of vascular closure devices55
5.2.2.3Product recalls and failures55
TABLE 3RECENT RECALLS OF VASCULAR CLOSURE DEVICES55
5.2.3OPPORTUNITIES56
5.2.3.1Emerging markets providing growth opportunities for market players56
5.2.3.2Growth in the number of hospitals & surgical centers56
5.2.4CHALLENGES56
5.2.4.1Need for highly skilled professionals56
5.2.4.2Risks associated with vascular closure devices57
5.2.4.3Stringent regulatory frameworks57
5.3COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET58
6VASCULAR CLOSURE DEVICES MARKET, BY TYPE60
6.1INTRODUCTION61
TABLE 4VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)61
TABLE 5VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)61
6.2PASSIVE APPROXIMATORS62
TABLE 6PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)62
TABLE 7PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)62
TABLE 8PASSIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)63
TABLE 9PASSIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)63
6.2.1COLLAGEN PLUGS63
6.2.1.1Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period63
TABLE 10COLLAGEN PLUGS MARKET, BY REGION, 2017–2020 (USD MILLION)64
TABLE 11COLLAGEN PLUGS MARKET, BY REGION, 2021–2026 (USD MILLION)64
6.2.2SEALANT OR GEL-BASED DEVICES65
6.2.2.1Sealant or gel-based devices to register the highest growth rate during the forecast period65
TABLE 12SEALANT OR GEL-BASED DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION)65
TABLE 13SEALANT OR GEL-BASED DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)66
6.2.3COMPRESSION ASSIST DEVICES66
6.2.3.1Compression assist devices do not leave behind any foreign body in the tissue artery—a major advantage of these devices66
TABLE 14COMPRESSION ASSIST DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION)66
TABLE 15COMPRESSION ASSIST DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)67
6.3ACTIVE APPROXIMATORS67
TABLE 16ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)67
TABLE 17ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)68
TABLE 18ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)68
TABLE 19ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)68
6.3.1SUTURE-BASED DEVICES69
6.3.1.1Increasing applications of suture-based devices to
favor market growth69
TABLE 20SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2017–2020 (USD MILLION)69
TABLE 21SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2021–2026 (USD MILLION)70
6.3.2CLIP-BASED DEVICES70
6.3.2.1Growing innovation in the field of clip-based devices to aid market growth70
TABLE 22CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2017–2020 (USD MILLION)71
TABLE 23CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2021–2026 (USD MILLION)71
6.4EXTERNAL HEMOSTATIC DEVICES71
6.4.1RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH71
TABLE 24EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION)72
TABLE 25EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)72
7VASCULAR CLOSURE DEVICES MARKET, BY ACCESS73
7.1INTRODUCTION74
TABLE 26VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)74
TABLE 27VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)74
7.2FEMORAL ACCESS75
7.2.1ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH75
TABLE 28FEMORAL ACCESS: RESEARCH STUDIES75
TABLE 29FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)76
TABLE 30FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)76
7.3RADIAL ACCESS77
7.3.1TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH—A KEY FACTOR DRIVING MARKET GROWTH77
TABLE 31RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION)77
TABLE 32RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)78
8VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE79
8.1INTRODUCTION80
TABLE 33VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)80
TABLE 34VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)80
8.2INTERVENTIONAL CARDIOLOGY81
8.2.1ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH81
TABLE 35VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017–2020 (USD MILLION)82
TABLE 36VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021–2026 (USD MILLION)82
8.3INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY83
8.3.1GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES83
TABLE 37VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION,
2017–2020 (USD MILLION)83
TABLE 38VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION,
2021–2026 (USD MILLION)84
9VASCULAR CLOSURE DEVICES MARKET, BY REGION85
9.1INTRODUCTION86
TABLE 39VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION)86
TABLE 40VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)86
9.2NORTH AMERICA87
FIGURE 20NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT88
TABLE 41NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)88
TABLE 42NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)89
TABLE 43NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)89
TABLE 44NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)89
TABLE 45NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)90
TABLE 46NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)90
TABLE 47NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)90
TABLE 48NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)91
TABLE 49NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)91
TABLE 50NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)91
TABLE 51NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)92
TABLE 52NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)92
9.2.1US92
9.2.1.1The US dominates the North American vascular closure
devices market92
TABLE 53REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 202093
TABLE 54US: KEY MACROINDICATORS94
TABLE 55US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)94
TABLE 56US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)95
TABLE 57US: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)95
TABLE 58US: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)95
TABLE 59US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)96
TABLE 60US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)96
TABLE 61US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)96
TABLE 62US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)97
TABLE 63US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)97
TABLE 64US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)97
9.2.2CANADA98
9.2.2.1Rising prevalence of target diseases to drive market growth98
TABLE 65CANADA: KEY MACROINDICATORS98
TABLE 66CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)99
TABLE 67CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)99
TABLE 68CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)99
TABLE 69CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)100
TABLE 70CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)100
TABLE 71CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)100
TABLE 72CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)101
TABLE 73CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)101
TABLE 74CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)101
TABLE 75CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)102
9.3EUROPE102
TABLE 76NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION,
BY COUNTRY, 2018102
TABLE 77EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY,
2017–2020 (USD MILLION)103
TABLE 78EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION)103
TABLE 79EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)103
TABLE 80EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)104
TABLE 81EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)104
TABLE 82EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)104
TABLE 83EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)105
TABLE 84EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)105
TABLE 85EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)105
TABLE 86EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)106
TABLE 87EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)106
TABLE 88EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)106
9.3.1E-3107
9.3.1.1Increase in number of radial procedures to boost the market demand107
TABLE 89GERMANY: KEY MACROINDICATORS107
TABLE 90UK: KEY MACROINDICATORS108
TABLE 91FRANCE: KEY MACROINDICATORS109
TABLE 92E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)110
TABLE 93E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)110
TABLE 94E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)110
TABLE 95E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)111
TABLE 96E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)111
TABLE 97E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)111
TABLE 98E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)112
TABLE 99E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)112
TABLE 100E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)112
TABLE 101E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)113
9.3.2REST OF EUROPE113
TABLE 102ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)114
TABLE 103ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)114
TABLE 104ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)115
TABLE 105ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)115
TABLE 106ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)115
TABLE 107ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)116
TABLE 108ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)116
TABLE 109ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)116
TABLE 110ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)117
TABLE 111ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)117
TABLE 112ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)117
9.4ASIA PACIFIC118
9.4.1INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC118
FIGURE 21ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT119
TABLE 113CHINA: KEY MACROINDICATORS120
TABLE 114JAPAN: KEY MACROINDICATORS121
TABLE 115INDIA: KEY INDICATORS122
TABLE 116ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)123
TABLE 117ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)123
TABLE 118ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)123
TABLE 119ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)124
TABLE 120ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)124
TABLE 121ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)124
TABLE 122ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)125
TABLE 123ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)125
TABLE 124ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)125
TABLE 125ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)126
9.5REST OF THE WORLD126
9.5.1GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH126
TABLE 126ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION)127
TABLE 127ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)127
TABLE 128ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)128
TABLE 129ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)128
TABLE 130ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION)128
TABLE 131ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION)129
TABLE 132ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION)129
TABLE 133ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION)129
TABLE 134ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION)130
TABLE 135ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION)130
10COMPETITIVE LANDSCAPE131
10.1OVERVIEW131
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN131
TABLE 136OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS131
10.3REVENUE SHARE ANALYSIS132
FIGURE 22REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET132
10.4MARKET SHARE ANALYSIS133
FIGURE 23VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020133
TABLE 137VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020)134

10.5COMPANY EVALUATION QUADRANT135
10.5.1STARS135
10.5.2EMERGING LEADERS135
10.5.3PERVASIVE PLAYERS135
10.5.4PARTICIPANTS135
FIGURE 24VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION
QUADRANT (2020)136
10.6COMPANY EVALUATION QUADRANT: SMES/START-UPS137
10.6.1PROGRESSIVE COMPANIES137
10.6.2STARTING BLOCKS137
10.6.3RESPONSIVE COMPANIES137
10.6.4DYNAMIC COMPANIES137
FIGURE 25VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)138
10.7COMPETITIVE SCENARIO139
10.7.1PRODUCT LAUNCHES & APPROVALS139
TABLE 138PRODUCT LAUNCHES & APPROVALS139
10.7.2DEALS140
TABLE 139DEALS140
10.7.3OTHER DEVELOPMENTS141
TABLE 140OTHER DEVELOPMENTS141
11COMPANY PROFILES142
11.1KEY PLAYERS142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1TERUMO CORPORATION142
TABLE 141TERUMO CORPORATION: BUSINESS OVERVIEW142
FIGURE 26TERUMO CORPORATION: COMPANY SNAPSHOT (2020)143
TABLE 142EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD)143
11.1.2ABBOTT LABORATORIES145
TABLE 143ABBOTT LABORATORIES: BUSINESS OVERVIEW145
FIGURE 27ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)146
11.1.3CARDINAL HEALTH148
TABLE 144CARDINAL HEALTH: BUSINESS OVERVIEW148
FIGURE 28CARDINAL HEALTH: COMPANY SNAPSHOT (2021)149
11.1.4CARDIVA MEDICAL, INC.151
TABLE 145CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW151
11.1.5MEDTRONIC PLC153
TABLE 146MEDTRONIC PLC: BUSINESS OVERVIEW153
FIGURE 29MEDTRONIC PLC: COMPANY SNAPSHOT (2021)154
11.1.6MORRIS INNOVATIVE, INC.156
TABLE 147MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW156
11.1.7TELEFLEX INCORPORATED157
TABLE 148TELEFLEX INCORPORATED: BUSINESS OVERVIEW157
FIGURE 30TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)158
11.1.8MERIT MEDICAL SYSTEMS, INC.160
TABLE 149MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW160
FIGURE 31MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)161
11.1.9VASORUM LTD.163
TABLE 150VASORUM LTD.: BUSINESS OVERVIEW163
11.1.10TZ MEDICAL, INC.165
TABLE 151TZ MEDICAL INC.: BUSINESS OVERVIEW165
11.2OTHER PLAYERS166
11.2.1VIVASURE MEDICAL LTD.166
11.2.2TRICOL BIOMEDICAL167
11.2.3SCION BIOMEDICAL168
11.2.4ADVANCED VASCULAR DYNAMICS169
11.2.5MARINE POLYMER TECHNOLOGIES, INC.170
11.2.6TRANSLUMINAL TECHNOLOGIES171
11.2.7REX MEDICAL172
11.2.8MERIL LIFE SCIENCES PVT. LTD.173
11.2.9MEDAS USA174
11.2.10VYGON COMPANY175
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX176
12.1INSIGHTS FROM INDUSTRY EXPERTS176
12.2DISCUSSION GUIDE177
12.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL180
12.4AVAILABLE CUSTOMIZATIONS182
12.5RELATED REPORTS182
12.6AUTHOR DETAILS183


お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com